MoglingBio Inc Alternatives & Competitors
12 companies similar to MoglingBio Inc — Rejuvenation of stem cells
Companies similar to MoglingBio Inc
Heartseed Inc.
Clinical-stage biotech company developing iPSC-derived highly purified ventricular cardiom...
Japan
Eugit Therapeutics
Tissue targeting of therapies
San Carlos, United States
YouthBio Therapeutics Inc.
Developing partial reprogramming gene therapies for Alzheimer’s and other diseases of agin...
Seattle, United States
Cellcolabs
Cellcolabs mission is to prevent and cure diseases by making high quality stem cells avail...
Solna, Sweden
Track all MoglingBio Inc competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Altos Labs
Altos Labs is a biotechnology company dedicated to unraveling the deep biology of cell rej...
Angeles Therapeutics, Inc.
A next generation CAR-T and CAR-NK cell therapy company
Los Angeles, United State...
Stembio Cell and Tissue Technologies Inc.
Our purpose is to build a leading, focused ATMPs company powered by advanced therapy platf...
Gebze, Turkey
Minerva Biotechnologies
We see the future first
Waltham, United States
APstem Therapeutics
An unprecedented era of stem cell therapy has arrived!
Fremont, United States
Mogrify
Transforming the lives of patients with degenerative diseases through a novel class of in...
Cambridge, United Kingdom
Ractigen Therapeutics
Turn on genes and turn off diseases
Suzhou, China
Revatis
An innovative patented and minimally invasive approach for obtaining stem cells
Belgium
About MoglingBio Inc
MoglingBio Inc, founded in 2022, is a promising player in the Health Care industry, headquartered in the United States. The company's focus is on developing novel pharmacological approaches aimed at the rejuvenation of old stem cells. Its innovative angle presents a significant opportunity within the burgeoning field o...
Development of pharmacological solutions for rejuvenating aged cells, Therapeutics targeting cellular aging and Cdc42 activity, Research in regenerative health and age-related disease interventions
Pharmaceutical Companies, Biotech Investors, Healthcare Providers, Research Institutions, Academic Collaborators
Stem Cell Rejuvenation, Pharmacological Approaches, Blood Cell Production, Immune Cell Production, Leukemia Prevention, Blood Disease Treatment, Cell Therapy, Regenerative Medicine, Therapeutic Development
B2B, B2D
Licensing, Product Sales, Service Fee
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches MoglingBio Inc and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at MoglingBio Inc on 26 Nov 2025. The 12 companies listed here were last checked between 12 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
